| Trial ID: | L5112 |
| Source ID: | NCT01193179
|
| Associated Drug: |
Opc-262
|
| Title: |
A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes, Type 2
|
| Interventions: |
DRUG: OPC-262
|
| Outcome Measures: |
Primary: Adverse events, clinical laboratory tests, 52 weeks | Secondary: Secondary Outcome HbA1c, 52 weeks
|
| Sponsor/Collaborators: |
Sponsor: Kyowa Kirin Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
450
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-07
|
| Completion Date: |
2012-04
|
| Results First Posted: |
|
| Last Update Posted: |
2014-01-08
|
| Locations: |
Kanto Rigeon, Japan|Kinki Region, Japan|Kyushu Region, Japan|Tohoku Region, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01193179
|
